Impact of Dual Antiplatelet Therapy on Superficial Femoral Artery Stent Patency in the Vascular Study Group of New England  Ryan M. Svoboda, Karina A.

Slides:



Advertisements
Similar presentations
Superficial Femoral Artery Recanalization with Self-expanding Nitinol Stents: Long-term Follow-up Results  M. Ferreira, L. Lanziotti, M. Monteiro, G.
Advertisements

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease  Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.
Bare metal stent infections: Case report and review of the literature
A patient with multiple paradoxical emboli
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Comparison of carotid endarterectomy and stenting in real world practice using a regional quality improvement registry  Brian W. Nolan, MD, MS, Randall.
Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents  Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.
Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score  Daniel M. Ihnat,
Misaki M. Kiguchi, MD, MBA, Luke K. Marone, MD, Rabih A
A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,
Danielle B. Cameron, BA, James H. Black, MD, Elliot K
Characteristics that define high risk in carotid endarterectomy from the Vascular Study Group of New England  Lindsay Gates, MD, Robert Botta, MD, Felix.
Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K
IP081. Patient-Tailored Postsurgical Survival Information from CARAT (the Carotid Risk Assessment Tool) Did Not Change Surgeons' Recommendations for Carotid.
Adjunctive use of the superficial femoral vein for vascular reconstructions  Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,
Jesse A. Columbo, Louise Davies, Ravinder Kang, J
The first operation on the profunda femoris artery
Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery  Randall R. De Martino,
PC180. Iliac-femoral Post-Thrombotic Syndrome: Three-Dimensional CT Venography for Preintervention Evaluation and Midterm Stent Patency Follow-up  Minyi.
Benefit of Arterial Duplex Ultrasound Stent Imaging After Superficial Femoral Artery Stent Implantation: Impact of Surveillance Method on Postprocedural.
Magdiel Trinidad-Hernandez, MD, Joseph J
Variation in thromboembolic complications among patients undergoing commonly performed cancer operations  Randall R. De Martino, MD, MS, Philip P. Goodney,
Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.
Remote endarterectomy: Lessons learned after more than 100 cases
Mesenteric stenting for chronic mesenteric ischemia
Philip P. Goodney, MD, Donald S. Likosky, PhD, Jack L. Cronenwett, MD 
Miguel Montero-Baker, MD, Gregory J
Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease  Mare M.A. Lensvelt, MD, Wilbert M. Fritschy,
Contemporary management of median arcuate ligament syndrome provides early symptom improvement  Jesse A. Columbo, MD, Thadeus Trus, MD, Brian Nolan, MD,
Derek de Grijs, MD, Pedro Teixeira, MD, Steven Katz, MD 
Possible consequences of regionally based bundled payments for diabetic amputations for safety net hospitals in Texas  Karina Newhall, MD, David Stone,
Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.
The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries  Jenny J. Lee, MD,
Bare metal stent infections: Case report and review of the literature
Chetan P. Huded, MD, Philip P. Goodney, MD, Richard J
Misaki M. Kiguchi, MD, MBA, Luke K. Marone, MD, Rabih A
Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery  Yoshimitsu.
Jesse A. Columbo, MD, Pablo Martinez-Camblor, PhD, Todd A
Completion duplex ultrasound predicts early graft thrombosis after crural bypass in patients with critical limb ischemia  Salvatore T. Scali, MD, Adam.
Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.
Ryan M. Svoboda, Kristina A. Giles, Samantha A. Connell, Daniel B
Primary stenting of the superficial femoral and popliteal artery
Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease  Robert W. Chang, MD, Philip P. Goodney,
Physician specialty and variation in carotid revascularization technique selected for Medicare patients  Jessica B. Wallaert, MD, MS, Brian W. Nolan,
Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.
Prior contralateral amputation predicts worse outcomes for lower extremity bypasses performed in the intact limb  Donald T. Baril, MD, Philip P. Goodney,
Reviewer Acknowledgment
Eric C. Scott, MD, Andre Biuckians, MD, MPH, Ryan E
Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease  Hasan H.
SS30. Late Outcomes of Different Hypogastric Stent Grafts in Aortoiliac Endografting With Iliac Branch Device: The pELVIS Registry  Fabio Verzini, Giambattista.
Dipankar Mukherjee, M. D. , William J. Schickler, M. D
Journal of Vascular Surgery
Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD 
RR13. Statin Therapy after Infrainguinal Bypass Surgery for Critical Limb Ischemia Is Associated with Improved Five-Year Survival  Bjoern D. Suckow, Larry.
Impact of practice patterns in shunt use during carotid endarterectomy with contralateral carotid occlusion  Philip P. Goodney, MD, MS, Jessica B. Wallaert,
Early results of stent-grafting to treat diffuse aortoiliac occlusive disease  Eva M Rzucidlo, MD, Richard J Powell, MD, Robert M Zwolak, MD, PhD, Mark.
The use of dextran and carbon dioxide for optical coherence tomography in the superficial femoral artery  Matthew T. Allemang, MD, Ryan O. Lakin, MD,
The Prevalence and Regional Variation of Major Depressive Disorder Among Patients With Peripheral Arterial Disease  Jesse A. Columbo, Christine T. Finn,
High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty 
Efficacious use of nitinol stents in the femoral and popliteal arteries  Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD 
True Radial Artery Aneurysm: Diagnosis and Treatment
The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis  Brian Nolan, MD,
Emily L. Spangler, MD, MS, Philip P
Emily Spangler, Robert W. Chang, Philip P. Goodney 
IP167. Patency at the Cost of Major Bleeding—the Dual-Antiplatelet Dilemma Following Lower Extremity Endovascular Intervention  Ryan M. Svoboda, MD, Carly.
Stroke and death after carotid endarterectomy and carotid artery stenting with and without high risk criteria  Kristina A. Giles, MD, Allen D. Hamdan,
Thigh claudication due to profunda femoris artery occlusion
Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W
Presentation transcript:

Impact of Dual Antiplatelet Therapy on Superficial Femoral Artery Stent Patency in the Vascular Study Group of New England  Ryan M. Svoboda, Karina A. Newhall, David H. Stone, Eva M. Rzucidlo, Jeremiah R. Brown, Philip P. Goodney  Journal of Vascular Surgery  Volume 64, Issue 4, (October 2016) DOI: 10.1016/j.jvs.2016.07.089 Copyright © 2016 Terms and Conditions

Fig Primary patency of superficial femoral artery (SFA) stents by antiplatelet regimen, up to 1 year. Journal of Vascular Surgery 2016 64, DOI: (10.1016/j.jvs.2016.07.089) Copyright © 2016 Terms and Conditions